The membrane-bound AR (mAR) can trigger cytoskeletal reorganizations via FAK/Cdc24/Rac1/PI3K and modulate the adhesive and migratory activity of prostate tumor cells [50,51] (Figure 3). Here, AR is linked to prostate neoplasm.